Novo’s Weight Loss Drugs Removed from FDA Shortage List
The U.S. Food and Drug Administration said on Friday there was no longer a shortage of Novo Nordisk’s popular weight-loss and diabetes drugs, Wegovy and Ozempic, a declaration that will curtail widespread sales of cheaper copies made by compounding pharmacies.
President Donald Trump and HHS Secretary Robert F. Kennedy Jr. said they will be studying the "threat" to children posed by ...
Local companies are developing technologies that they hope could replace a painful poke with something that feels more like ...
It’s normal to have lots of questions when you start a new prescription medication. Whether you can drink alcohol might be at ...
Senators questioned Novo Nordisk CEO Lars Jørgensen on Tuesday at a hearing over the costs of Ozempic, Wegovy and similar weight loss drugs, which are cheaper in other countries. The CEO of ...
American demand for weight-loss drugs is supercharging Denmark’s economy and transforming a small Danish community into an ...
Doctors say drugs that improve muscle mass could benefit older or infirm people at greater risk of falls and fractures ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback